New Asthma Drug ‘Shows Massive Promise’ For Patients
Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. If you have asthma your airways are always inflamed. They become even more swollen and the muscles around the airways can tighten when something triggers your symptoms.”Asthma drug ‘gamechanger’ could revolutionise treatment,” The Guardian reports after a new drug showed promising results in a small study of 61 people with moderate to severe asthma.Asthma is a lung condition that can cause inflammation of the airways, which can lead to breathing difficulties. asthma is a minor nuisance.
While many people can control the condition with existing drugs, a minority of people only have a partial response to treatment, so their quality of life can be adversely affected.This trial aimed to investigate whether new Asthma Drug reduced airway inflammation in people with moderate to severe asthma associated with raised levels of eosinophils, the particular white blood cell linked to asthma.The 12-week trial compared new Drug with placebo in 61 adults. The drug was added to any medication they were already taking.
The main outcome was on the percentage of eosinophils in their sputum, which did decrease by a greater amount in the new Asthma Drug group. It also had a beneficial effect on quality of life, but no effect on overall asthma control or symptoms.The potential implications of the research were summed up succinctly by Dr Samantha Walker, Director of Research and Policy at Asthma UK, who said: “This research shows massive promise and should be greeted with cautious optimism.”These initial findings are promising, but more studies will be needed to confirm that the drug is safe and has a definite effect on asthma control compared with other treatments.